Noland Hagood
Family Medicine · Arkadelphia, ARNPI 1346259124
Payments from drug & device makers
Across 250 payments — averaging $13.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$561
- Dexcom, Inc.$367
- Lilly USA, LLC$335
- Pfizer$314
- Abbott$293
- Amgen$244
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,33999%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $561 |
| Dexcom, Inc. | 25 | $367 |
| Lilly USA, LLC | 32 | $335 |
| Pfizer | 27 | $314 |
| Abbott | 16 | $293 |
| Amgen | 16 | $244 |
| AstraZeneca | 10 | $183 |
| GSK | 8 | $144 |
| Astellas Pharma US Inc | 6 | $116 |
| Novo Nordisk | 7 | $107 |
| Merck | 7 | $95 |
| Boehringer Ingelheim | 5 | $72 |
| Nestle Healthcare Nutrition Inc. | 5 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Novartis | 3 | $49 |
| Bayer | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| Exact Sciences | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Almatica Pharma LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
How this compares
$3,369 in reported general payments places this provider in the 80th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 258 | $177,679 |
| JardianceEmpagliflozin | 198 | $138,006 |
| OzempicSemaglutide | 63 | $65,956 |
| MounjaroTirzepatide | 57 | $57,258 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 87 | $56,267 |
| FarxigaDapagliflozin Propanediol | 69 | $46,100 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 107 | $30,841 |
| TrulicityDulaglutide | 31 | $29,454 |
| XareltoRivaroxaban | 36 | $24,609 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $16,878 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 103 | $14,398 |
| LinzessLinaclotide | 12 | $11,607 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $11,119 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $10,678 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $9,239 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $314 | $177,679258 claims |
| Boehringer IngelheimJardiance | $72 | $138,006198 claims |
| Lilly USA, LLCMounjaro, Trulicity | $335 | $86,71288 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $144 | $78,902140 claims |
| Novo NordiskOzempic | $107 | $65,95663 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $183 | $53,13780 claims |
| Johnson & JohnsonXarelto | $12 | $24,60936 claims |
| AbbVieLinzess | $561 | $11,60712 claims |
| Sanofi-aventis U.S. LLCMultaq, Lantus | $12 | $7,73046 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Arkadelphia
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.